Related Experiment Video
Updated: Feb 21, 2026
The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
Methylphenidate increases selectivity of visual scanning in children referred for hyperactivity
Methylphenidate increased visual scanning selectivity in children with hyperactivity symptoms, focusing more on task standards. However, this enhanced attention did not reduce overall errors, suggesting stimulants can improve focus without necessarily boosting performance.
Area of Science:
- Neuroscience
- Developmental Psychology
- Pharmacology
Background:
- Hyperactivity symptoms in children are often associated with attention deficits.
- Methylphenidate is a common stimulant medication used to manage ADHD symptoms.
- Understanding how methylphenidate affects visual scanning is crucial for optimizing treatment.
Purpose of the Study:
- To investigate the impact of methylphenidate on visual scanning patterns in children with hyperactivity.
- To compare the effects of methylphenidate versus placebo on attentional selectivity during a visual task.
Main Methods:
- A double-blind, crossover study involving 32 children with hyperactivity symptoms.
- Assessment of visual scanning using computer-generated visual matching-to-sample problems.
- Recording of total errors, response latency, and visual fixations under methylphenidate and placebo conditions.
Main Results:
- Methylphenidate significantly increased fixations on the standard stimulus.
- The drug also led to more systematic comparisons between stimuli.
- Increased attentional selectivity was observed, but total errors did not decrease.
Conclusions:
- Methylphenidate can enhance attentional selectivity in children with hyperactivity.
- Improved focus does not always translate to better task performance.
- Stimulant medication may modulate attention independently of task outcome.
More Related Videos
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
13:09Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
Published on: April 1, 2018
Related Concept Videos
01:30Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
01:28Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
01:25Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
01:16Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...